BioCryst Pharmaceuticals, Inc.

Develops small-molecule drugs for treatment of immunological, viral, and cardiovascular diseases and disorders, using structure-based drug design. Includes programs, trials and investors' profile, with headquarters in Birmingham, Alabama. (Nasdaq: BCRX)